| NCT ID | NCT07237295 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of North Carolina, Chapel Hill |
| Condition | Chronic Kidney Disease (Stages 1-4) |
| Study Type | INTERVENTIONAL |
| Enrollment | 634 participants |
| Start Date | 2026-04-13 |
| Primary Completion | 2028-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 634 participants in total. It began in 2026-04-13 with a primary completion date of 2028-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In the United States, the burden of chronic kidney disease (CKD) rests disproportionately on rural communities. This study evaluates the implementation and effectiveness of CommunityRx-Kidney Health (CRx-K); this health information technology intervention integrates medical, social, and self-care resources to improve CKD management in rural eastern North Carolina. Through a partnership among local primary care centers, community organizations, and researchers, CRx-K will strengthen rural care networks, improve CKD management, and enhance the well-being of rural communities.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of chronic kidney disease defined as ≥1 ICD-10 CKD codes (excluding end-stage kidney disease) or CKD biomarkers (estimated glomerular filtration rate ≤ 60 ml/min, albuminuria ≥30 mg/24h) * At least one clinic visit at Goshen Medical Center in 12 months before enrollment Exclusion Criteria: * Limited life expectancy (e.g., advanced cancer, end-stage liver disease, hospice) * Active cancer treatment * Living in a skilled nursing facility * Dementia/other significant cognitive impairment/inability to participate in the informed consent process
Contact & Investigator
Gaurav J Dave, MBBS, MPH, DrPH
PRINCIPAL INVESTIGATOR
University of North Carolina, Chapel Hill
Frequently Asked Questions
Who can join the NCT07237295 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Kidney Disease (Stages 1-4). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07237295 currently recruiting?
Yes, NCT07237295 is actively recruiting participants. Contact the research team at CRx-K@med.unc.edu for enrollment information.
Where is the NCT07237295 trial being conducted?
This trial is being conducted at Beulaville, United States.
Who is sponsoring the NCT07237295 clinical trial?
NCT07237295 is sponsored by University of North Carolina, Chapel Hill. The principal investigator is Gaurav J Dave, MBBS, MPH, DrPH at University of North Carolina, Chapel Hill. The trial plans to enroll 634 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.